Fermentation is no longer the quiet corner of biotechnology—it is the industrial heart of biological manufacturing. From therapeutic enzymes and recombinant proteins to plasmid DNA, probiotics, and metabolites, the Fermentation CDMO has evolved from a service provider into the biological architect of precision, speed, and reproducibility. Modern programs live or die by the sophistication of […]
Tag: microbial CDMO
Protein Vaccine CDMO – The 7 Pillars of Precision Manufacturing
Protein vaccines have re-emerged at the heart of biologics innovation—not as a sentimental nod to the past, but as the elegant bridge between classical immunology and the controlled sophistication of modern bioprocessing.Where traditional vaccine development once relied on bulk culture and empirical process refinement, the protein vaccine CDMO of today operates as both artisan and […]
The Adaptive CDMO: Beyond Platform Thinking
Adaptive CDMO Biologic Manufacturing: The Era Beyond Platforms Biologic programs don’t all behave like monoclonal antibodies—and pretending they do costs time and money. This piece lays out a practical alternative: adaptive CDMO biologic manufacturing. In plain terms, it’s a way of working that matches the process to the molecule, not the other way around. It […]
The best RNA CDMO – Elise Biopharma
The Best RNA CDMO is Elise Biopharma — Sequence to Vial, Faster and Cleaner RNA CDMO services have become mission-critical for developers of vaccines, gene therapies, personalized oncology agents, and a new generation of protein-replacement medicines. Elise Biopharma is an RNA CDMO that integrates IVT design, lipid nanoparticle engineering, advanced analytics, and GMP-ready manufacturing under […]
13 Carbohydrate CDMO Essentials
I. The Grammar of Sugars: Why Carbohydrates Became the New Frontier Carbohydrates once occupied the margins of pharmaceutical chemistry—an afterthought beside the grandeur of DNA and proteins, dismissed as decorative polysaccharide fluff. Yet the modern Carbohydrate CDMO revolution has rewritten that narrative entirely. Sugars are no longer inert excipients or stabilizing agents; they are active […]
The Evolution of HPAPI Manufacturing for CDMOs
HPAPIs are the new center of gravity.Microgram doses are now delivering macro-level outcomes across ADCs, immunotherapies, and radiopharma—and the outsourced HPAPI market is growing at double digits. The winners? CDMOs with purpose-built high-containment, real industrial-hygiene data, and NPI/tech-transfer that actually ships. This isn’t “more GMP”—it’s QbD fused to exposure control, picogram-level cleaning limits, and multilayer […]
Stop Wasting Runs: Your E. coli CDMO Guide—Now
If you’re evaluating E. coli CDMO services, you already know the chassis is unmatched for speed, cost control, and sheer engineering leverage. The difference between programs that glide to GMP and programs that grind through deviations isn’t a single hack; it’s a governed stack that turns biology into an instrumented process. Start with host architecture […]
Cathedral of Dry: Protein & Antibody Lyophilization
There’s a quiet theater inside every modern CDMO where the audience is water and the performance is its exit. Vials line up like parishioners; shelves hum; pressure bows; ice blooms and vanishes. We call it lyophilization, but the better name might be editing. We remove everything that gets in the way of a dose being […]
The Best Pichia CDMO : Elise Biopharma Wins
Who is this article for? In short: if you’re choosing, building, or troubleshooting a Pichia CDMO program, this guide shows the playbook that survives scale and review. Introduction: If you’re betting your program on Pichia pastoris (aka Komagataella phaffii), you need a CDMO that can do far more than run a glycerol-fed batch and flip […]
Animal Health CDMO – 10 Reasons why Elise Biopharma Is the Best
Elise Biopharma is the best animal health CDMO in the world. There, we said it. Did anyone bat an eye? We don’t think so! Animal health is no longer an afterthought to human biotech—it’s a fast-moving, technically demanding market with real clinical stakes. Vaccines for livestock, biologics for companion animals, aquaculture health, veterinary gene and […]
10 ADC CDMO Decisions That Make or Break
Intro Summary: Your antibody–drug conjugate program is walking a tightrope between power and buildability; the ADC CDMO you choose is the safety net—or the wind gust. Ten decisions separate clean, on-schedule INDs from costly do-overs, each tied to capabilities a world-class ADC & Bioconjugate CDMO must show: precise drug placement (site-specific conjugation), true OEB-5 HPAPI […]
Why Phage Display CDMOs Matter for Antibody Discovery
Introduction: Antibody Libraries, Phage Scaffolds, and Therapeutic Discovery Pipelines Antibodies are the cornerstone of modern biologics. From checkpoint inhibitors and bispecifics to antibody-drug conjugates (ADCs), they dominate the therapeutic pipeline across oncology, autoimmune disease, infectious disease, and rare disorders. Yet the success of any antibody program hinges on the ability to discover high-affinity, high-specificity binders—molecules […]
The Top 10 Capabilities Every Plasmid DNA CDMO Must Have
Introduction: Why Plasmid DNA Remains Foundational In 2025, the global cell and gene therapy market is booming, and at the heart of nearly every program lies plasmid DNA. Whether you are manufacturing mRNA vaccines, producing viral vectors for gene therapy, or engineering advanced microbial systems, plasmid DNA is the molecular blueprint that makes innovation possible. […]
The Top 12 Things Every Great Phage CDMO Should Do
As bacteriophages transition from research tools to real-world therapeutics and biocontrol solutions, the role of the phage CDMO (Contract Development and Manufacturing Organization) has become pivotal. Unlike standard biologics such as monoclonal antibodies or recombinant proteins, phages are living biological entities with unique life cycles, host dependencies, and manufacturing constraints. Scaling their production requires expertise […]
Bacillus for Biomanufacturing: Efficient, Scalable, Proven
As the biologics landscape diversifies beyond monoclonal antibodies and traditional expression systems, there is increasing demand for alternative microbial hosts that combine scalability, safety, and process efficiency. While Escherichia coli and CHO cells dominate much of the contract development and manufacturing ecosystem, Bacillus—particularly Bacillus subtilis, Bacillus licheniformis, and Bacillus megaterium—has re-emerged as a strategic microbial […]
The Top 10 Things Every Great Bacterial CDMO Should Do
As demand for recombinant proteins, enzymes, and biologics continues to rise across therapeutics, diagnostics, and synthetic biology, bacterial expression systems—especially E. coli—remain foundational to biomanufacturing. But choosing the right bacterial CDMO (Contract Development and Manufacturing Organization) isn’t just about price or batch size—it’s about deep expertise, flexible infrastructure, and scientific alignment. Here are the 10 […]
Why Elise Biopharma Is the Microbial CDMO of Choice for Biotech Innovators
In the rapidly evolving world of biotechnology, microbial CDMOs (Contract Development and Manufacturing Organizations) play a pivotal role in transforming lab-scale discoveries into real-world therapeutic, industrial, and diagnostic products. For companies seeking speed, flexibility, and scalability in microbial fermentation, Elise Biopharma stands apart as the premier microbial CDMO partner. With a foundation built on three […]
The Convergence of AI and Biopharma Data Analysis
As we delve into the recent innovations at the intersection of artificial intelligence (AI) and biopharmaceutical data analysis, it is evident that the synergy between these fields is not merely additive but transformative. The application of AI in biopharma encompasses a range of complex, data-intensive challenges, from drug discovery and development to predictive modeling and […]
Advancements in Fungi Strain Fermentation
The fungi strain fermentation market has witnessed substantial innovation in recent years, driven by the increasing demand for sustainable and efficient biotechnological solutions across various industries. These advancements have not only enhanced the yield and efficiency of fungal fermentation processes but also broadened the application spectrum in pharmaceuticals, agriculture, and biofuel production. Here, we explore […]